|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.77 GBX | -1.32% |
|
-6.06% | -3.63% |
| 09/02 | Avacta appoints new chief scientific officer, plans clinical trials | AN |
| 09/02 | Avacta Therapeutics Names Chemistry Vice President as Chief Scientific Officer | MT |
Insiders
Search
No results for this search
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















